These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 31235817)
1. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy. Lu Q; Chen YB; Yang H; Wang WW; Li CC; Wang L; Wang J; Du L; Yin XX Acta Pharmacol Sin; 2019 Dec; 40(12):1555-1567. PubMed ID: 31235817 [TBL] [Abstract][Full Text] [Related]
2. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy. Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815 [TBL] [Abstract][Full Text] [Related]
3. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition. Kang MK; Park SH; Choi YJ; Shin D; Kang YH J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793 [TBL] [Abstract][Full Text] [Related]
4. YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis. Yang T; Shu F; Yang H; Heng C; Zhou Y; Chen Y; Qian X; Du L; Zhu X; Lu Q; Yin X Metabolism; 2019 Jul; 96():33-45. PubMed ID: 31028762 [TBL] [Abstract][Full Text] [Related]
5. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy. Du L; Qian X; Li Y; Li XZ; He LL; Xu L; Liu YQ; Li CC; Ma P; Shu FL; Lu Q; Yin XX Acta Pharmacol Sin; 2021 Feb; 42(2):242-251. PubMed ID: 32555442 [TBL] [Abstract][Full Text] [Related]
6. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1. Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483 [TBL] [Abstract][Full Text] [Related]
7. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy. Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104 [TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy. Lee GH; Cheon J; Kim D; Jun HS Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142408 [TBL] [Abstract][Full Text] [Related]
9. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis. Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130 [TBL] [Abstract][Full Text] [Related]
10. Silencing of angiotensin II type-1 receptor inhibits high glucose-induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells via inactivation of mTOR/p70S6K signaling pathway. Gong Q; Hou F Biochem Biophys Res Commun; 2016 Jan; 469(2):183-8. PubMed ID: 26626074 [TBL] [Abstract][Full Text] [Related]
11. P4HB regulates the TGFβ/SMAD3 signaling pathway through PRMT1 to participate in high glucose-induced epithelial-mesenchymal transition and fibrosis of renal tubular epithelial cells. Wang H; Li Y; Wu N; Lv C; Wang Y BMC Nephrol; 2024 Sep; 25(1):297. PubMed ID: 39251943 [TBL] [Abstract][Full Text] [Related]
12. Tuberous sclerosis 1 (Tsc1) mediated mTORC1 activation promotes glycolysis in tubular epithelial cells in kidney fibrosis. Cao H; Luo J; Zhang Y; Mao X; Wen P; Ding H; Xu J; Sun Q; He W; Dai C; Zen K; Zhou Y; Yang J; Jiang L Kidney Int; 2020 Sep; 98(3):686-698. PubMed ID: 32739207 [TBL] [Abstract][Full Text] [Related]
13. Protein arginine methyltranferase-1 induces ER stress and epithelial-mesenchymal transition in renal tubular epithelial cells and contributes to diabetic nephropathy. Chen YY; Peng XF; Liu GY; Liu JS; Sun L; Liu H; Xiao L; He LY Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2563-2575. PubMed ID: 31199999 [TBL] [Abstract][Full Text] [Related]
14. Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition. Das NA; Carpenter AJ; Belenchia A; Aroor AR; Noda M; Siebenlist U; Chandrasekar B; DeMarco VG Cell Signal; 2020 Apr; 68():109506. PubMed ID: 31862399 [TBL] [Abstract][Full Text] [Related]
15. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice. Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805 [TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease. Hu Y; Tang W; Liu W; Hu Z; Pan C Drug Des Devel Ther; 2022; 16():1605-1620. PubMed ID: 35669284 [TBL] [Abstract][Full Text] [Related]
17. LncRNA KIFAP3-5:1 inhibits epithelial-mesenchymal transition of renal tubular cell through PRRX1 in diabetic nephropathy. Du L; Lu Y; Wang J; Zheng Y; Li H; Liu Y; Wu X; Zhou J; Wang L; He L; Shi J; Xu L; Li X; Lu Q; Yin X Cell Biol Toxicol; 2024 Jun; 40(1):47. PubMed ID: 38869718 [TBL] [Abstract][Full Text] [Related]